animal models

Successful drug development programs require animal models that more faithfully replicate the human disease condition.

Advantages of CNS | DIABETES AND LIVER FIBROSIS GEN’s Animal Models...

in vivo gene theraPY

Development of strategies for correcting gene expression in vivo in mice models of disease...

animal behaviour

GeN serves to assist clients with the testing and evaluation of novel therapeutic agents and to identify products that may be suitable for clinical trials in an efficient and cost-effective manner. We specialize in cognition testing (Learning, Memory...)

Cell systems

TESTING COMPOUNDS IN PARTNERSHIP WITH:

• Alysson Muotri, UC San Diego Health Sciences

• Afraxis, San Diego, USA

Biomarkers: OMICS

To correlate genetic markers to mechanisms of disease and gain further inside into disease aetiology, we perform a multi-level –omics approach using tissues and peripheral fluid biomarkers.

Drug discovery

Our team developed novel drug discovery programs for Alzheimer’s disease and neurodevelopmental syndromes.

We utilize innovative, drug discovery, genomic and proteomic technologies, which offer the promise to shed...

advice

PRECLINICAL DRUG DEVELOPMENT

We offer expert advise in preclinical studies designed to identify a lead candidate from several hits; develop the best procedure for new drug scale-up; select the best formulation; determine the route, frequency, and duration of exposure; and ultimately support the intended clinical trial design.

PARTNER WITH US TO DEVELOP THE NEXT RARE DISEASE THERAPY

In ten years, we’ve delivered new treatments towards the clinic and FDA approved drugs. We develop partnerships to patent some of these treatments out and to the clinic-ready treatments with Neuren Pharmaceuticals, AMO Pharmaceuticals, Tetra Bio-Pharma and Ovid Pharmaceuticals.

Contact Us

GeN Ltd
Office 7 35-37 Ludgate Hill
London, England
EC4M 7JN

+442071938819

patricia.cogram@genddi.co.uk

diseño alauna